Navigation Links
CO2 capture: Health effects of amines and their derivatives
Date:4/4/2011

CO2 capture by means of amines is considered to be the most appropriate method to quickly begin with CO2 removal. During this capture process, some of the amines escaping the recycling process will be emitted into the air and will also form other compounds such as nitrosamines and nitramines. The Norwegian Institute of Public Health (NIPH) was commissioned by the Climate and Pollution Agency (Klif) to assess whether these new emissions are harmful to health - particularly in terms of the cancer risk to the general population. The results of the risk assessments were submitted recently.

These amines by themselves are not very harmful at typical concentrations that might occur, for example, near power plants. However, the amines could take part in complex chemical reactions and form new compounds such as nitrosamines and nitramines, which can affect health and the environment.

There is relatively little knowledge about the various health effects for many of these compounds, but it is known that several of them can be highly carcinogenic. The cancer risk ultimately depends on how much is formed, how much is released, how much is decomposed in the atmosphere by light and how strong the cancer-causing substances are.

The NIPH has assessed the cancer-causing ability of compounds that can be formed in connection with CO2 capture. Nitrosodimethylamine (NDMA) was found to be one of those that may be the most carcinogenic. Therefore, this compound is used to calculate the risk from the total amount of various nitrosamines in the air.

Uncertainty about nitramines

There is a lack of knowledge about nitramines but the compounds in this group are generally believed to be less carcinogenic than nitrosamines. However, studies show that the nitramine we know most about, (N-nitrodimethylamine) is a highly carcinogenic substance, although it is not as potent as NDMA.

The NIPH recommends that the risk estimate for NDMA is also used for nitramines. This must be regarded as a risk estimate that will provide good protection of the population. If nitramines are detected in significant quantities in emissions, there will be a need for more knowledge for the NIPH to be able to perform a full risk evaluation.

Recommendation

When released from the CO2 capture plant, the NIPH recommends that the risk estimate for NDMA should be used for the total concentration of both nitrosamines and nitramines in air and water. We recommend maximum levels that provide minimal or negligible risk of cancer from exposure to these substances. The NIPH therefore concludes that the total amount of nitrosamines and nitramines should not exceed 0.3 ng/m3 (nanogram/m3) air.


'/>"/>

Contact: Julie Johansen
julie.johansen@fhi.no
Norwegian Institute of Public Health
Source:Eurekalert

Related medicine news :

1. Carolinas HealthCare System Volunteers to Join Navy Rescue Mission in Haiti
2. SXC Health Solutions to Host Fiscal 2009 Fourth Quarter and Year End Results Conference Call
3. A New Website Series Improves Appearance and Health City by City
4. Diet-to-Go Welcomes 2 Key Philadelphia Fitness Centers as Partners-in-Health
5. Quantum Health Appoints Stark as Executive Vice President of Sales
6. New Report: The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels
7. Satellite Healthcares Sheila Doss Elected Western Chapters Coordinator-Elect of the American Nephrology Nurses Association
8. Changing the Course of Kids Health
9. Mental Health America Encourages Journalists, Media Professionals to Submit Entries for 2010 Media Awards
10. Idaho House Moves State Closer to Health Care Disaster
11. UNT Health Science Centers Roby Helps Identify Bodies of Chiles Patio 29
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... ... May 03, 2016 , ... Horizon Blue ... been honored as one of the nation’s most accomplished business technology innovators by ... received the recognition for technology achievements that have enabled the delivery of the ...
(Date:5/3/2016)... ... 03, 2016 , ... BioPlus Specialty Pharmacy (BioPlus), one ... 2016 Asembia Specialty Pharmacy Summit held May 2-6, 2016 at the Wynn & ... conference for the specialty pharmacy industry, with thousands of pharmacy providers, pharma/biotech manufacturers, ...
(Date:5/3/2016)... (PRWEB) , ... May 03, 2016 , ... ... announced that it is launching a new client service center in La Vergne, ... Texas, and will provide the full range of Empyrean client services. , “Our ...
(Date:5/3/2016)... ... May 03, 2016 , ... Park Cities Pet Sitter ... or adjacent to the 75204, 75205, 75206, 75209, 75219, 75220, 75225, 75229, 75230, 75231 ... Bluffview, Midway Hollow, North Dallas, Plano, Preston Hollow and Park Cities areas of the ...
(Date:5/3/2016)... ... May 03, 2016 , ... For ... top Information and Communication Technology (ICT) companies in the annual Branham300 listing. For ... operating in Canada, as ranked by revenue. , “We are honored to ...
Breaking Medicine News(10 mins):
(Date:5/2/2016)... NEW YORK , May 2, 2016 ... the EMR (Electronic Medical Records) market in a recent ... International sales, vendor switches, Increased physician usage, a growing market ... trends were noted in Kalorama,s report EMR ... The report marks Kalorama,s seventh complete study of the ...
(Date:5/2/2016)... N.J. , May 2, 2016  Celsion ... development company, today announced data from the first ... escalating clinical trial (the OVATION Study) combining GEN-1, ... care for the treatment of newly-diagnosed patients with ... followed by interval debulking surgery.  In the first ...
(Date:4/29/2016)... , April 29, 2016 ... for Life Sciences, Product Development Capabilities in ... Science Customer Base . Indegene ... today announced the acquisition of Skura Corporation,s life ... leader in adaptive sales enablement technology for life ...
Breaking Medicine Technology: